The Jackson Laboratory Launches Online Portal to Give Researchers Access to Neurodegenerative Disease iPSC Lines

The Jackson Laboratory, in partnership with the Chan Zuckerberg Initiative and the National Institute for Health is now offering a catalog of human induced pluripotent stem cells (iPSCs).

With just a few clicks of a mouse and taps on a keyboard, researchers from around the world can now order induced pluripotent stem cells (iPSCs) that National Institutes of Health (NIH) Center for Alzheimer’s and Related Dementias (CARD) scientists have specially engineered for studying the genes behind Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and several other neurodegenerative disorders. The iPSCs stem cells can be obtained from a web portal administrated by The Jackson Laboratory.

Neurodegenerative disorders represent a group of diseases that, over time, damage different parts of the nervous system and cause debilitating problems, including dementia and paralysis. Over the past few decades, scientists have discovered hundreds of diseasing-causing gene variants that may be linked to several cases of these diseases.

The available cell lines contain gene variants linked to the following neurodegenerative disorders:

• Alzheimer’s disease
• Parkinson’s disease
• ALS
• Frontotemporal Dementia

For more information, read the entire article at The Jackson Laboratory here.